Comments
Cadila Healthcare board has approved raising up to Rs 18,500 crore through various financial tools, including issue of securities in domestic as well as international markets.
The board has considered and approved in-principle for various fund-raising proposals, Cadila Healthcare said in a regulatory filing today.
The company said the fund-raising could be via issue of shares or convertible bonds or debentures through qualified institutional placement (QIP) for an aggregate amount of up to Rs 10,000 crore.
The board of directors also approved issuing secured/unsecured redeemable non-convertible debentures/foreign currency bonds on a private placement basis for an amount up to Rs 3,500 crore during the current fiscal, it said.
Besides, the board also approved issuing foreign currency bonds/foreign currency convertible bonds (FCCBs) for an amount up to Rs 5,000 crore.
The company however did not elaborate as how it plans to utilise the capital.
Headquartered in Ahmedabad, Zydus Cadila group has global operations in four continents spread across the US, Europe, Latin America and South Africa and 25 other emerging markets.
The group’s operations cover healthcare solutions ranging from formulations, active pharmaceutical ingredients and animal healthcare products to wellness products.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.